High risk genes with established predictions with surveillance recommendations |
APC |
5q22.2 |
611731 |
colorectal, pancreatic, desmoid, hepatoblastoma, glioma, other CNS |
adenomatous polyposis coli; Turcot syndrome |
AD |
yes |
BMPR1A |
10q23.2 |
601299 |
gastrointestinal polyps |
juvenile polyposis |
AD |
yes |
BRCA1 |
17q21.31 |
113705 |
breast, ovarian |
hereditary breast/ovarian cancer |
AD |
yes |
BRCA2 |
13q13.1 |
600185 |
breast, ovarian, pancreatic, leukaemia |
hereditary breast/ovarian cancer |
AD |
yes |
CDH1 |
16q22.1 |
192090 |
gastric |
familial gastric carcinoma |
AD |
no |
CDK4 |
12q14.1 |
123829 |
melanoma |
familial malignant melanoma |
AD |
no |
CDKN2A |
9p21.3 |
600160 |
melanoma, pancreatic |
familial malignant melanoma |
AD |
no |
EPCAM |
2p21 |
185535 |
colorectal |
Colorectal cancer, hereditary nonpolyposis, type 8 |
AD |
no |
FH |
1q43 |
136850 |
leiomyomatosis, renal |
hereditary leiomyomatosis and renal cell cancer |
AD |
no |
FLCN |
17p11.2 |
607273 |
renal, fibrofolliculomas, trichodiscomas |
Birt-Hogg-Dube syndrome |
AD |
no |
MEN1 |
11q13.1 |
613733 |
parathyroid adenoma, pituitary adenoma, pancreatic islet cell, carcinoid |
multiple endocrine neoplasia type 1 |
AD |
yes |
MLH1 |
3p22.2 |
120436 |
colorectal, endometrial, ovarian, central nervous system |
hereditary non-polyposis colorectal cancer, Turcot syndrome |
AD |
yes |
MSH2 |
2p21-p16 |
609309 |
colorectal, endometrial, ovarian |
hereditary non-polyposis colorectal cancer |
AD |
yes |
MSH6 |
2p16.3 |
600678 |
colorectal, endometrial, ovarian |
hereditary non-polyposis colorectal cancer |
AD |
yes |
MUTYH |
1p34.1 |
604933 |
colorectal |
adenomatous polyposis coli |
AR |
yes |
NF1 |
17q11.2 |
613113 |
neurofibroma, glioma |
neurofibromatosis type 1 |
AD |
no |
NF2 |
22q12.2 |
607379 |
meningioma, acoustic neuroma |
neurofibromatosis type 2 |
AD |
yes |
PMS2 |
7p22.1 |
600259 |
colorectal, endometrial, ovarian, medulloblastoma, glioma |
hereditary non-polyposis colorectal cancer, Turcot syndrome |
AD |
yes |
PTCH1 |
1p34.1 |
603673 |
skin basal cell, medulloblastoma |
nevoid basal cell carcinoma syndrome |
AD |
no |
PTEN |
10q23.31 |
601728 |
harmartoma, glioma, prostate, endometrial |
Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome |
AD |
yes |
RB1 |
13q14.2 |
614041 |
retinoblastoma, sarcoma, breast, small cell lung carcinoma |
familial retinoblastoma |
AD |
yes |
RET |
10q11.21 |
164761 |
medullary thyroid, papillary thyroid, pheochromocytoma |
multiple endocrine neoplasia 2A/2B |
AD |
yes |
SDHB |
1p36.13 |
185470 |
paraganglioma, pheochromocytoma |
familial paraganglioma |
AD |
yes |
SDHD |
11q23.1 |
602690 |
paraganglioma, pheochromocytoma |
familial paraganglioma |
AD |
yes |
SDHAF2 |
11q12.2 |
613019 |
paraganglioma |
familial paraganglioma |
AD |
yes |
SDHC |
1q23.3 |
602413 |
paraganglioma, pheochromocytoma |
familial paraganglioma |
AD |
yes |
SMAD4 |
18q21.2 |
600993 |
gastrointestinal polyp |
juvenile polyposis |
AD |
yes |
STK11 |
19p13.3 |
602216 |
jejunal hamartoma, ovarian, testicular, pancreatic |
Peutz-Jeghers syndrome |
AD |
yes |
TGFBR2 |
3p24.1 |
190182 |
colorectal |
Hereditary Nonpolyposis Colorectal Cancer type 6 |
AD |
yes |
TP53 |
17p13.1 |
191170 |
breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types |
Li-Fraumeni syndrome |
AD |
yes |
TSC1 |
9q34.13 |
605284 |
hamartoma, renal cell carcinoma, tuberous sclerosis tuber |
Tuberous sclerosis 1 |
AD |
yes |
TSC2 |
16p13.3 |
191092 |
hamartoma, renal cell carcinoma, tuberous sclerosis tuber |
Tuberous sclerosis 2 |
AD |
yes |
VHL |
3p25.3 |
608537 |
renal, haemangioma, pheochromocytoma |
Von Hippel-Lindau syndrome |
AD |
yes |
WT1 |
11p13 |
607102 |
Wilms tumour |
Denys-Drash syndrome, Frasier syndrome, familial Wilms tumour |
AD |
yes |
FANCA |
16q24.3 |
607139 |
Acute myeloid leukemia, leukaemia |
Fanconi anaemia complementation group A |
AR |
no |
FANCB |
Xp22.2 |
300515 |
Acute myeloid leukemia, leukaemia |
Fanconi anemia, complementation group B |
XLR |
no |
FANCC |
9q22.32 |
613899 |
Acute myeloid leukemia, leukaemia |
Fanconi anaemia complementation group C |
AR |
no |
FANCD2 |
3p25.3 |
613984 |
Acute myeloid leukemia, leukaemia |
Fanconi anaemia complementation group D2 |
AR |
no |
FANCE |
6p21.31 |
613976 |
Acute myeloid leukemia, leukaemia |
Fanconi anaemia complementation group E |
AR |
no |
FANCF |
11p14.3 |
613897 |
Acute myeloid leukemia, leukaemia |
Fanconi anaemia complementation group F |
AR |
no |
FANCG |
9p13.3 |
602956 |
Acute myeloid leukemia, leukaemia |
Fanconi anaemia complementation group G |
AR |
no |
FANCL |
2p16.1 |
608111 |
Acute myeloid leukemia, leukaemia |
Fanconi anemia, complementation group L |
AR |
no |
EGFR |
7p11.2 |
131550 |
Non-small-cell lung carcinoma |
familial lung cancer |
AR |
no |
ERCC2 |
19q13.32 |
126340 |
skin basal cell, skin squamous cell, melanoma |
Xeroderma pigmentosum, group D |
AR |
no |
ERCC3 |
2q14.3 |
133510 |
skin basal cell, skin squamous cell, melanoma |
Xeroderma pigmentosum, group B |
AR |
no |
ERCC4 |
16p13.12 |
133520 |
skin basal cell, skin squamous cell, melanoma |
Xeroderma pigmentosum, group F |
AR |
no |
ERCC5 |
13q33.1 |
133530 |
skin basal cell, skin squamous cell, melanoma |
Xeroderma pigmentosum, group G |
AR |
no |
EXT1 |
8q24.11 |
608177 |
exostoses, osteosarcoma |
multiple exostoses type 1 |
AR |
no |
NBN |
8q21.3 |
602667 |
Non-Hodgkin lymphoma, glioma, medulloblastoma, rhabdomyosarcoma |
Nijmegen breakage syndrome |
AR |
no |
Moderate/increased risk genes that are acknowledged guidelines screening and risk reduction measures in accordance with family history |
ALK |
2p23.2-p23.1 |
105590 |
neuroblastoma |
familial neuroblastoma |
AD |
no |
ATM |
11q22.3 |
607585 |
leukaemia, lymphoma, medulloblastoma, glioma |
ataxia-telangiectasia |
AD |
no |
BAP1 |
3p21.1 |
603089 |
mesothelioma, uveal melanoma |
Tumor predisposition syndrome |
AD |
no |
BRIP1 |
17q23.2 |
605882 |
AML, leukaemia, breast |
Fanconi anaemia J, breast cancer susceptiblity |
AD |
no |
CHEK2 |
22q12.1 |
604373 |
breast |
familial breast cancer |
AD |
no |
PALB2 |
16p12.2 |
610355 |
Wilms tumour, medulloblastoma, AML, breast |
Fanconi anaemia N, breast cancer susceptibility |
AD |
no |
RAD51C |
17q22 |
602774 |
Breast,ovarian cancer |
Breast-ovarian cancer, familial, susceptibility to, 3 |
AD |
no |
RAD51D |
17q12 |
602954 |
Breast,ovarian cancer |
Breast-ovarian cancer, familial, susceptibility to, 4 |
AD |
no |
Genes that have moderate or high risk based on published studies but pending professional recommendations regarding surveillance and risk reduction strategies |
ATR |
3q23 |
601215 |
oropharyngeal |
familial cutaneous telangiectasia and cancer syndrome, Seckel Syndrome |
AD |
no |
AXIN2 |
17q24.1 |
604025 |
colorectal carcinoma |
oligodontia-colorectal cancer syndrome |
AD |
no |
BARD1 |
2q35 |
601593 |
ovarian cancer, breast cancer, endometrioid cancer |
AD |
no |
BLM |
15q26.1 |
604610 |
leukaemia, lymphoma, skin squamous cell, other tumour types |
Bloom syndrome |
AD |
no |
CDC73 |
1q31.2 |
607393 |
parathyroid adenoma, multiple ossifying jaw fibroma |
hyperparathyroidism-jaw tumour syndrome |
AD |
no |
CDKN1B |
12p13.1 |
600778 |
pituitary, parathyroid |
multiple endocrine neoplasia type IV |
AD |
no |
DICER1 |
14q32.13 |
606241 |
pleuropulmonary blastoma |
familial pleuropulmonary blastoma or DICER1 syndrome |
AD |
no |
EXT2 |
11p11.2 |
608210 |
exostoses, osteosarcoma |
multiple exostoses type 2 |
AD |
no |
GALNT12 |
9q22.33 |
610290 |
colorectal |
Colorectal cancer, susceptibility to, 1 |
AD |
no |
HNF1A |
12q24.31 |
142410 |
hepatic adenoma, hepatocellular carcinoma |
familial hepatic adenoma |
AD |
no |
HOXB13 |
17q21-q22 |
604607 |
prostate |
Prostate cancer, hereditary, 9 |
AD |
no |
HRAS |
11p15.5 |
190020 |
rhabdomyosarcoma, ganglioneuroblastoma, bladder |
Costello syndrome |
AD |
no |
KDR |
4q12 |
191306 |
melanoma |
Hemangioma, capillary infantile, susceptibility to |
AD |
no |
KIT |
4q12 |
164920 |
gastrointestinal, epithelioma |
familial gastrointestinal stromal tumour |
AD |
no |
MAX |
14q23.3 |
154950 |
pheochromocytoma |
Pheochromocytoma, susceptibility to |
AD |
no |
MITF |
3p13 |
156845 |
melanoma |
Melanoma, cutaneous malignant, susceptibility to, 8 |
AD |
no |
PDGFRA |
4q12 |
173490 |
gastrointestinal stromal tumour |
familial gastrointestinal stromal tumour |
AD |
no |
PHB |
17q21.33 |
176705 |
Breast cancer |
{Breast cancer, susceptibility to} |
AD |
no |
PHOX2B |
4p13 |
603851 |
neuroblastoma |
familial neuroblastoma |
AD |
no |
POLD1 |
19q13.33 |
174761 |
colorectal |
Lynch syndrome |
AD |
no |
PRF1 |
10q22.1 |
170280 |
various leukaemia, lymphoma |
AD |
no |
PRKAR1A |
17q24.2 |
188830 |
myxoma, endocrine, papillary thyroid |
Carney complex |
AD |
no |
RAD50 |
5q31.1 |
604040 |
breast cancer |
Nijmegen breakage syndrome-like disorder |
AR |
no |
RAD51A |
15q15.1 |
179617 |
breast cancer |
?Fanconi anemia, complementation group R |
AD |
no |
RAD54L |
1p34.1 |
603615 |
breast cancer |
Breast cancer, invasive ductal |
AD |
no |
SDHA |
5p15.33 |
600857 |
paraganglioma |
paragangliomas-5 (PGL5) |
AD |
no |
SMARCB1 |
22q11.23 |
601607 |
malignant rhabdoid |
rhabdoid predisposition syndrome |
AD |
no |
SMARCE1 |
17q21.2 |
603111 |
meningioma |
Meningioma, familial, susceptibility to |
AD |
no |
TERT |
5p15.33 |
187270 |
melanoma |
Melanoma, cutaneous malignant, 9 |
AD |
no |
TMEM127 |
2q11.2 |
613403 |
pheochromocytoma, renal cell carcinoma |
Pheochromocytoma, susceptibility to |
AD |
no |
DDB2 |
11p11.2 |
600811 |
skin basal cell, skin squamous cell, melanoma |
xeroderma pigmentosum (E) |
AR |
no |
RECQL4 |
8q24.3 |
603780 |
osteosarcoma, skin basal cell, skin sqamous cell |
Rothmund-Thompson syndrome |
AR |
no |
XPA |
9q22.33 |
611153 |
skin basal cell, skin squamous cell, melanoma |
xeroderma pigmentosum (A) |
AR |
no |
XPC |
3p25.1 |
613208 |
skin basal cell, skin squamous cell, melanoma |
xeroderma pigmentosum (C) |
AR |
no |
SUFU |
10q24.32 |
607035 |
medulloblastoma |
medulloblastoma predisposition |
AR, AD |
no |
GPC3 |
Xq26.2 |
300037 |
Wilms tumour |
Simpson-Golabi-Behmel syndrome |
XLR |
no |
WAS |
Xp11.23 |
300392 |
lymphoma |
Wiskott-Aldrich syndrome |
XLR |
no |